AMA M2, specific autoantibodies for PBC, was detected in 87% of patients’ sera and specific anti-nuclear antibodies—anti-gp210 autoantibodies were positive in 39% of patients. This evidence concerns the gene NUP210 and primary biliary cholangitis.